Prelude Therapeutics cut the ribbon on its new headquarters on Friday morning, signaling the next chapter in the company's growth.
MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
WILMINGTON – Solenis, the global producer of specialty chemicals used in water-intensive industries, has outgrown its leased research-and-development space, and is now looking to invest more than $35 million to […]
The next big thing in innovation. There’s a stretch of Route 141 that was once known as “DuPont Row.” It runs past several sites the chemical giant has at sometime […]
WILMINGTON – A recent state report underlined the growing importance and impact of pharmaceutical, biotechnology and health care research firms collectively known as life sciences in Delaware, an industry that […]
Premier Digital Partners
© 2024 Delaware Business Times
